Concepedia

Author

John Mendoza

Christus Stehlin Foundation for Cancer Research

Also Known As

J T Mendoza, J. T. Mendoza, JOHN MENDOZA, John MENDOZA, John Mendoza, John T. Mendoza

25

Publications

534

Citations

11

H-Index

23

Concepts

All Affiliations

Christus Stehlin Foundation for Cancer ResearchSt. Joseph Hospital
JM

About

John Mendoza is an author at Christus Stehlin Foundation for Cancer Research specializing in cell biology, tumor biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

231

2

Cell Biology

6

6

231

3

Pharmacology

5

5

154

4

Health Sciences

3

3

173

5

Pathology

1

1

21

John Mendoza

×

13

Publications

471

Citations

11

H-Index

YearCitations

Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins.

Panayotis Pantazis, Hellmuth R. Hinz, John Mendoza,

PubMed

1992

85

Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.

Panayotis Pantazis, Janet Early, Anthony J. Kozielski,

PubMed

1993

67

Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells <i>in vitro</i>

Panayotis Pantazis, Anthony J. Kozielski, John Mendoza,

International Journal of Cancer

1993

59

Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.

Qian Li, Claire F. Verschraegen, John Mendoza,

PubMed

2004

59

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

Claire F. Verschraegen, Wei Hu, Yu Du,

PubMed

2003

56

Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.

Panayotis Pantazis, Janet Early, John Mendoza,

PubMed

1994

37

9‐nitro‐camptothecin delays growth of U‐937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines<i>in vitro</i>

Panayotis Pantazis, John Mendoza, Janet Early,

European Journal Of Haematology

1993

22

Desmoplastic small round cell tumor (DSRCT) xenografts and tissue culture lines: Establishment and initial characterization

Constantine Markides, D Coil, Linh H. Luong,

Oncology Letters

2013

21

Structure‐Activity Relationship of Alkyl Camptothecin Esters

Zhisong Cao, PANAYOTIS FANTAZIS, John Mendoza,

Annals of the New York Academy of Sciences

2000

19

Partial characterization of human leukemia U‐937 cell sublines resistant to 9‐nitrocamptothecin P

Panayotis Pantazis, John Mendoza, A. DeJesus,

European Journal Of Haematology

1994

14

Page 1